We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+7.97%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$27.3B
AUM Growth
+$1.17B
Cap. Flow
-$1B
Cap. Flow %
-3.68%
Top 10 Hldgs %
13.33%
Holding
1,440
New
99
Increased
518
Reduced
438
Closed
115

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$58.6M
2
CHTR icon
Charter Communications
CHTR
+$45.8M
3
CACC icon
Credit Acceptance
CACC
+$44.9M
4
HD icon
Home Depot
HD
+$43M
5
ADSK icon
Autodesk
ADSK
+$40.5M

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$77.5M
2
AAPL icon
Apple
AAPL
+$73.3M
3
META icon
Meta Platforms (Facebook)
META
+$64.7M
4
MRK icon
Merck
MRK
+$58.9M
5
QCOM icon
Qualcomm
QCOM
+$56.8M

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Healthcare 16.1%
3 Financials 11.41%
4 Consumer Discretionary 10.23%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNP icon
51
Union Pacific
UNP
$169B
$115M 0.42%
705,480
-316,195
-31% -$47.6M
SYK icon
52
Stryker
SYK
$108B
$115M 0.42%
645,613
-5,705
-0.9% -$974K
ILCG icon
53
iShares Morningstar Growth ETF
ILCG
$3.09B
$108M 0.4%
2,913,615
+80,500
+3% +$2.92M
MA icon
54
Mastercard
MA
$503B
$105M 0.39%
471,969
-1,205
-0.3% -$251K
VZ icon
55
Verizon
VZ
$213B
$105M 0.38%
1,958,398
-313,000
-14% -$16.6M
PFE icon
56
Pfizer
PFE
$158B
$104M 0.38%
2,493,807
+157,327
+7% +$6.06M
MMM icon
57
3M
MMM
$83.6B
$104M 0.38%
589,989
+62,918
+12% +$10.8M
ROK icon
58
Rockwell Automation
ROK
$46.5B
$104M 0.38%
553,313
-24,980
-4% -$4.47M
AMGN icon
59
Amgen
AMGN
$206B
$103M 0.38%
498,807
+7,341
+1% +$1.45M
VRTX icon
60
Vertex Pharmaceuticals
VRTX
$132B
$103M 0.38%
532,576
-271,505
-34% -$48.3M
CDNS icon
61
Cadence Design Systems
CDNS
$76.9B
$102M 0.38%
2,257,916
-492,025
-18% -$22.4M
ALXN
62
DELISTED
Alexion Pharmaceuticals
ALXN
$102M 0.37%
733,643
-303,854
-29% -$38.1M
LITE icon
63
Lumentum
LITE
$74.9B
$102M 0.37%
1,700,589
+60,277
+4% +$3.61M
CELG
64
DELISTED
Celgene Corp
CELG
$101M 0.37%
1,124,541
-213,526
-16% -$18.9M
PG icon
65
Procter & Gamble
PG
$339B
$100M 0.37%
1,205,824
+243,803
+25% +$19.9M
XLNX
66
DELISTED
Xilinx Inc
XLNX
$94.6M 0.35%
1,180,089
-48,620
-4% -$3.56M
TER icon
67
Teradyne
TER
$51.5B
$94.5M 0.35%
2,556,223
-134,502
-5% -$5.42M
BRK.B icon
68
Berkshire Hathaway Class B
BRK.B
$1.1T
$93.1M 0.34%
434,863
+47,265
+12% +$9.7M
SBUX icon
69
Starbucks
SBUX
$113B
$92.6M 0.34%
1,628,972
-368,983
-18% -$19.5M
TJX icon
70
TJX Companies
TJX
$139B
$91.3M 0.34%
1,630,550
-344,938
-17% -$17.7M
LYB icon
71
LyondellBasell Industries
LYB
$20.3B
$90.9M 0.33%
886,772
-42,394
-5% -$4.64M
BAC icon
72
Bank of America
BAC
$416B
$90.6M 0.33%
3,075,697
-682,654
-18% -$20.8M
BKNG icon
73
Booking.com
BKNG
$132B
$90.5M 0.33%
1,140,175
-408,300
-26% -$32.1M
KO icon
74
Coca-Cola
KO
$384B
$87.6M 0.32%
1,896,815
+404,834
+27% +$18.5M
HOLX
75
DELISTED
Hologic
HOLX
$87.5M 0.32%
2,135,489
-85,844
-4% -$3.47M

Similar funds

Axa's Q3 2018 Portfolio in Review

As of Q3 2018, Axa held 1,440 positions worth $27.3B, up 4.5% from $26.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Axa withdrew a net $1B in Q3 2018, closing 115 positions and reducing 438 holdings. Its most notable exit was CA, Inc., an estimated $56.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Axa opened a new position in KKR & Co worth $27.3M.

  • Axa's largest Q3 2018 buy was KKR & Co: 1,000,000 shares worth $27.3M.
  • Axa added most to Intel in Q3 2018, an estimated $58.6M increase.
  • Axa's biggest Q3 2018 reduction was DexCom, cutting an estimated $77.5M.
  • Axa fully exited CA, Inc. in Q3 2018, selling an estimated $56.1M.
  • Axa's ten largest holdings make up 13% of its $27.3B portfolio in Q3 2018.
  • Axa opened 99 new positions and closed 115 in Q3 2018.
  • Axa's portfolio value rose 4.5% quarter-over-quarter to $27.3B.

Based on Axa's 13F filing for Q3 2018, filed 8 Nov 2018.